RADHAKISHAN PHARMACEUTICALS
BORTECAD  BORTEZOMIB INJECTION

BORTECAD BORTEZOMIB INJECTION

MOQ : 1 Bottle

BORTECAD BORTEZOMIB INJECTION Specification

  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Salt Composition
  • Bortezomib
  • Indication
  • Multiple Myeloma, Mantle Cell Lymphoma
  • Dosage Form
  • Injection
  • Origin of Medicine
  • Imported
  • Drug Type
  • Allopathic
  • Ingredients
  • Bortezomib
  • Physical Form
  • Liquid
  • Function
  • Anti-Cancer
  • Recommended For
  • As directed by physician
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Follow healthcare providers instructions
  • Suitable For
  • Adults
  • Quantity
  • 1 Vial
  • Storage Instructions
  • Store below 25C. Protect from light.
  • Route of Administration
  • Intravenous or Subcutaneous
  • Use under medical supervision
  • Yes
  • Brand Name
  • Bortecad
  • Shelf Life
  • 24 Months
  • Pack Type
  • Vial
  • Marketed By
  • Cadila Healthcare Ltd.
  • Strength
  • 2 mg/vial
  • Prescription/Non prescription
  • Prescription
 

BORTECAD BORTEZOMIB INJECTION Trade Information

  • Minimum Order Quantity
  • 1 Bottle
  • Packaging Details
  • PACK OF 1 VIAL
 

About BORTECAD BORTEZOMIB INJECTION

PRODUCT DETAILS

BRAND NAME: BORTECAD

CONTENT: BORTEZOMIB

STRENGTH: 2MG

PACKAGING: PACK OF 1 VIAL

MANUFACTURED BY: CADILA

Note:-Bortecad Is APrescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From AProblem That Is Not Effectively Treated By This Drug.............



Precisely Formulated Anti-Cancer Therapy

Bortecad is formulated with bortezomib, a potent anti-cancer agent. It is particularly effective in managing multiple myeloma and mantle cell lymphoma, offering targeted action against malignant cells. As an allopathic injection, it acts directly through the bloodstream, allowing for rapid therapeutic response.


Safe Administration and Usage Guidelines

This medication is available only under prescription and should be administered intravenously or subcutaneously by medical professionals. Dosage and treatment duration are tailored to each patient by the physician. Following healthcare provider instructions is critical to ensure optimal efficacy and minimize risks.


Storage and Handling Precautions

Bortecad requires careful storage below 25C, protected from direct light to preserve its stability and effectiveness. Always keep the packaging intact until use and handle with medical supervision. The recommended shelf life ensures potency for up to two years from manufacturing.

FAQs of BORTECAD BORTEZOMIB INJECTION:


Q: How is Bortecad (Bortezomib Injection) administered?

A: Bortecad is administered either intravenously or subcutaneously by a healthcare professional in a clinical setting. The exact route and dosage depend on the patients specific medical condition and physicians instructions.

Q: What conditions is Bortecad recommended for?

A: Bortecad is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma. Its anti-cancer properties make it suitable for targeting malignant cells in these conditions.

Q: When should Bortecad be used during treatment?

A: Bortecad should be used as part of a prescribed anti-cancer regimen and only under strict medical supervision. The timing and duration of treatment are determined by the physician based on individual patient needs.

Q: Where should Bortecad be stored before administration?

A: Bortecad must be stored below 25C in a cool, dark place, away from direct sunlight. Maintaining recommended conditions ensures the injections stability and potency until use.

Q: What is the process for using Bortecad safely?

A: This medication should always be prepared and administered by qualified healthcare providers. Patients must follow dosage and scheduling instructions precisely, as directed by their physician, to reduce risks and maximize therapeutic benefit.

Q: What are the benefits of Bortecad in cancer therapy?

A: Bortecad delivers targeted anti-cancer effects, helping manage and treat multiple myeloma and mantle cell lymphoma. It contributes to reducing cancer cell proliferation and may improve overall patient outcomes when used as part of a comprehensive treatment plan.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

Carbokast Carboplatin Injection

Carbokast Carboplatin Injection

Minimum Order Quantity : 1 Bottle

Origin of Medicine : Allopathic

Dosage : 150mg/45ml

Physical Form : Liquid

Dosage Guidelines : As directed by the physician

Storage Instructions : Store below 25C, Protect from light

CINACALCET TABLETS 30 MG

CINACALCET TABLETS 30 MG

Origin of Medicine : Allopathic

Dosage : As directed by physician; common dose is 30 mg once daily

Physical Form : Tablets

Dosage Guidelines : Take orally with food or shortly after a meal; do not crush or chew the tablet

Storage Instructions : Store below 30C, protect from moisture and light

FEMISTRA ANASTROZOLE TABLETS

FEMISTRA ANASTROZOLE TABLETS

Origin of Medicine : Allopathic

Dosage : 1 mg once daily or as directed by physician

Physical Form : Tablets

Dosage Guidelines : Take orally, do not exceed recommended dose

Storage Instructions : Store in a cool, dry place away from direct sunlight

DACLACURE  DACLATASVIR DIHYDROCHLORIDE TABLETS

DACLACURE DACLATASVIR DIHYDROCHLORIDE TABLETS

Origin of Medicine : Allopathic

Dosage : 60 mg

Physical Form : Tablets

Dosage Guidelines : As directed by the physician; generally one tablet daily.

Storage Instructions : Store in a cool, dry place below 30C. Protect from light and moisture.



Back to top